(BN) Brookfield - Ratings and Ratios
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA11271J1075
BN: Real Estate, Renewable Energy, Infrastructure, Investment Management
Brookfield Corporation (NYSE:BN) is a leading global alternative asset manager and Real Estate Investment Trust (REIT) specializing in real estate, renewable power, infrastructure, and private equity. With over $750 billion in assets under management, Brookfield is one of the largest players in the alternative investment space. The firm manages a diverse range of public and private investment vehicles, catering to both institutional and retail clients. Brookfields investment strategy focuses on acquiring high-quality, large-scale assets across geographies and sectors, leveraging its own capital alongside that of its investors. This approach allows the firm to maintain control and flexibility in its investments.
In private equity, Brookfield targets underperforming or distressed assets, focusing on sectors with significant real asset exposure, such as industrials, infrastructure, and business services. The firms private equity portfolio includes investments in automotive manufacturing, healthcare infrastructure, and energy distribution. Brookfield also has a strong presence in renewable energy, owning and operating wind farms, solar projects, and hydroelectric facilities. Its real estate investments span office, retail, and logistics properties in major global cities. The firms investment horizon typically ranges from four to ten years, with a focus on long-term value creation through operational improvements and strategic restructuring. Brookfields global footprint includes offices in North America, Europe, Asia, and South America, enabling it to identify and capitalize on investment opportunities worldwide.
3-Month Forecast
Based on the technical and fundamental data, Brookfield Corporations stock is expected to face short-term headwinds. The last price of $49.70 is below its 20-day and 50-day moving averages ($50.77 and $53.81, respectively), indicating downward momentum. The stock may encounter resistance at the 200-day moving average ($53.08). The average true range (ATR) of 2.42 suggests moderate volatility over the next three months.
From a fundamental perspective, Brookfields high P/E ratio (149.16) compared to its forward P/E (12.15) indicates potential overvaluation in the near term. However, the low price-to-sales (P/S) ratio of 0.85 and the firms strong market position in alternative assets may signal undervaluation. The return on equity (RoE) of 1.27% reflects modest profitability, which could impact investor sentiment. Overall, the stock is likely to remain under pressure in the short term but may present long-term value as the market recalibrates its expectations.
Additional Sources for BN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BN Stock Overview
Market Cap in USD | 75,704m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 1983-12-30 |
BN Stock Ratings
Growth Rating | 61.4 |
Fundamental | 14.4 |
Dividend Rating | 18.5 |
Rel. Strength | 8.56 |
Analysts | 3.78/5 |
Fair Price Momentum | 46.14 USD |
Fair Price DCF | - |
BN Dividends
Dividend Yield 12m | 0.65% |
Yield on Cost 5y | 1.35% |
Annual Growth 5y | -3.73% |
Payout Consistency | 95.8% |
BN Growth Ratios
Growth Correlation 3m | -87.3% |
Growth Correlation 12m | 73.9% |
Growth Correlation 5y | 57.9% |
CAGR 5y | 15.46% |
CAGR/Max DD 5y | 0.37 |
Sharpe Ratio 12m | 1.30 |
Alpha | 19.11 |
Beta | 1.474 |
Volatility | 60.27% |
Current Volume | 3771.8k |
Average Volume 20d | 3631.9k |
As of April 24, 2025, the stock is trading at USD 50.05 with a total of 3,771,779 shares traded.
Over the past week, the price has changed by +1.44%, over one month by -9.58%, over three months by -14.91% and over the past year by +27.22%.
Neither. Based on ValueRay Fundamental Analyses, Brookfield is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.35 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BN as of April 2025 is 46.14. This means that BN is currently overvalued and has a potential downside of -7.81%.
Brookfield has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold BN.
- Strong Buy: 2
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, BN Brookfield will be worth about 52.1 in April 2026. The stock is currently trading at 50.05. This means that the stock has a potential upside of +4%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 66.8 | 33.4% |
Analysts Target Price | 67.9 | 35.6% |
ValueRay Target Price | 52.1 | 4% |